These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9615709)

  • 1. Deletion of chromosome 3p is an early event in malignant progression of cervical cancer.
    Guo Z; Wilander E; Sällström J; Pontén J
    Anticancer Res; 1998; 18(2A):707-12. PubMed ID: 9615709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite instability is a late event in the carcinogenesis of uterine cervical cancer.
    Nishimura M; Furumoto H; Kato T; Kamada M; Aono T
    Gynecol Oncol; 2000 Nov; 79(2):201-6. PubMed ID: 11063644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
    Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion mapping of chromosome 3p in human uterine cervical cancer.
    Kohno T; Takayama H; Hamaguchi M; Takano H; Yamaguchi N; Tsuda H; Hirohashi S; Vissing H; Shimizu M; Oshimura M
    Oncogene; 1993 Jul; 8(7):1825-32. PubMed ID: 8099726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic lesion in the carcinogenesis of cervical cancer.
    Chung GT; Huang DP; Lo KW; Chan MK; Wong FW
    Anticancer Res; 1992; 12(5):1485-90. PubMed ID: 1359830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer.
    Zhuang Z; Merino MJ; Chuaqui R; Liotta LA; Emmert-Buck MR
    Cancer Res; 1995 Feb; 55(3):467-71. PubMed ID: 7834608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
    Rosin MP; Cheng X; Poh C; Lam WL; Huang Y; Lovas J; Berean K; Epstein JB; Priddy R; Le ND; Zhang L
    Clin Cancer Res; 2000 Feb; 6(2):357-62. PubMed ID: 10690511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic loss on chromosome 1 is associated with tumor progression of cervical carcinoma.
    Cheung TH; Chung TK; Poon CS; Hampton GM; Wang VW; Wong YF
    Cancer; 1999 Oct; 86(7):1294-8. PubMed ID: 10506716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease.
    Yoon DS; Li L; Zhang RD; Kram A; Ro JY; Johnston D; Grossman HB; Scherer S; Czerniak B
    Oncogene; 2001 Aug; 20(36):5005-14. PubMed ID: 11526485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of chromosome 3p deletions in human epithelial ovarian tumors.
    Lounis H; Mes-Masson AM; Dion F; Bradley WE; Seymour RJ; Provencher D; Tonin PN
    Oncogene; 1998 Nov; 17(18):2359-65. PubMed ID: 9811467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of p53 gene mutation and loss of heterozygosity of 3p, 9p and 17p in precancerous lesions of 29 lung cancer patients.
    Nishisaka T; Takeshima Y; Inai K
    Hiroshima J Med Sci; 2000 Jun; 49(2):109-16. PubMed ID: 10920577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy.
    Kozlowski L; Filipowski T; Rucinska M; Pepinski W; Janica J; Skawronska M; Poznanski J; Wojtukiewicz MZ
    Neoplasma; 2006; 53(5):440-3. PubMed ID: 17013540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity at 3p in benign lesions preceding invasive breast cancer.
    Euhus DM; Maitra A; Wistuba II; Alberts A; Albores-Saavedra J; Gazdar AF
    J Surg Res; 1999 May; 83(1):13-8. PubMed ID: 10210636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer.
    Srivatsan ES; Chakrabarti R; Zainabadi K; Pack SD; Benyamini P; Mendonca MS; Yang PK; Kang K; Motamedi D; Sawicki MP; Zhuang Z; Jesudasan RA; Bengtsson U; Sun C; Roe BA; Stanbridge EJ; Wilczynski SP; Redpath JL
    Oncogene; 2002 Aug; 21(36):5631-42. PubMed ID: 12165862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mutation and allelic loss of chromosome 3p, 9p of preneoplastic lesions in patients with nonsmall cell lung carcinoma.
    Kohno H; Hiroshima K; Toyozaki T; Fujisawa T; Ohwada H
    Cancer; 1999 Jan; 85(2):341-7. PubMed ID: 10023701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic progression and heterogeneity associated with the development of esophageal squamous cell carcinoma.
    Roth MJ; Hu N; Emmert-Buck MR; Wang QH; Dawsey SM; Li G; Guo WJ; Zhang YZ; Taylor PR
    Cancer Res; 2001 May; 61(10):4098-104. PubMed ID: 11358832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.